rs1883414
|
HLA-DPB2
|
Kidney Diseases
|
|
0.800 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs1883414
|
HLA-DPB2
|
Kidney Diseases
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs3117027
|
HLA-DPB2
|
cervical cancer
|
|
0.720 |
GeneticVariation |
BEFREE |
<i>Conclusion.</i> HLA-DP gene polymorphisms (HLA-DPB1⁎03:01, DPB1⁎04:02, DPB1⁎13:01, rs9277535, and rs3117027) were significantly associated with cervical cancer.
|
30009173 |
2018 |
rs3117027
|
HLA-DPB2
|
Cervix carcinoma
|
|
0.720 |
GeneticVariation |
BEFREE |
<i>Conclusion.</i> HLA-DP gene polymorphisms (HLA-DPB1⁎03:01, DPB1⁎04:02, DPB1⁎13:01, rs9277535, and rs3117027) were significantly associated with cervical cancer.
|
30009173 |
2018 |
rs3117027
|
HLA-DPB2
|
cervical cancer
|
|
0.720 |
GeneticVariation |
BEFREE |
No association was observed between rs3117027 and risk of cervical cancer.
|
24403192 |
2014 |
rs3117027
|
HLA-DPB2
|
Cervix carcinoma
|
|
0.720 |
GeneticVariation |
BEFREE |
No association was observed between rs3117027 and risk of cervical cancer.
|
24403192 |
2014 |
rs3117027
|
HLA-DPB2
|
Cervix carcinoma
|
|
0.720 |
GeneticVariation |
GWASCAT |
Three independent loci in the major histocompatibility complex (MHC) region at 6p21.3 were associated with cervical cancer: the first is adjacent to the MHC class I polypeptide-related sequence A gene (MICA) (rs2516448; OR = 1.42, 95% CI = 1.31 to 1.54; P = 1.6×10(-18)); the second is between HLA-DRB1 and HLA-DQA1 (rs9272143; OR = 0.67, 95% CI = 0.62 to 0.72; P = 9.3×10(-24)); and the third is at HLA-DPB2 (rs3117027; OR=1.25, 95% CI = 1.15 to 1.35; P = 4.9×10(-8)).
|
23482656 |
2013 |
rs3117027
|
HLA-DPB2
|
cervical cancer
|
|
0.720 |
GeneticVariation |
GWASDB |
Three independent loci in the major histocompatibility complex (MHC) region at 6p21.3 were associated with cervical cancer: the first is adjacent to the MHC class I polypeptide-related sequence A gene (MICA) (rs2516448; OR = 1.42, 95% CI = 1.31 to 1.54; P = 1.6×10(-18)); the second is between HLA-DRB1 and HLA-DQA1 (rs9272143; OR = 0.67, 95% CI = 0.62 to 0.72; P = 9.3×10(-24)); and the third is at HLA-DPB2 (rs3117027; OR=1.25, 95% CI = 1.15 to 1.35; P = 4.9×10(-8)).
|
23482656 |
2013 |
rs9380343
|
HLA-DPB2
|
Hepatitis B
|
|
0.710 |
GeneticVariation |
BEFREE |
The current study is the first report demonstrating the HLA rs9380343 polymorphism as a genetic risk factor for chronicity of HBV infection.
|
31290749 |
2019 |
rs9380343
|
HLA-DPB2
|
Hepatitis B
|
|
0.710 |
GeneticVariation |
GWASDB |
A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population.
|
21750111 |
2011 |
rs9380343
|
HLA-DPB2
|
Hepatitis B
|
|
0.710 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.
|
19349983 |
2009 |
rs117232140
|
HLA-DPB2
|
Body Height
|
|
0.700 |
GeneticVariation |
GWASCAT |
Characterizing rare and low-frequency height-associated variants in the Japanese population.
|
31562340 |
2019 |
rs3117006
|
HLA-DPB2
|
Attention deficit hyperactivity disorder
|
|
0.700 |
GeneticVariation |
GWASCAT |
Shared genetics of asthma and mental health disorders: a large-scale genome-wide cross-trait analysis.
|
31619474 |
2019 |
rs3117006
|
HLA-DPB2
|
Asthma
|
|
0.700 |
GeneticVariation |
GWASCAT |
Shared genetics of asthma and mental health disorders: a large-scale genome-wide cross-trait analysis.
|
31619474 |
2019 |
rs1883414
|
HLA-DPB2
|
IGA Glomerulonephritis
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.
|
25305756 |
2014 |
rs3117008
|
HLA-DPB2
|
cervical cancer
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
rs3117039
|
HLA-DPB2
|
cervical cancer
|
A |
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
rs3129275
|
HLA-DPB2
|
cervical cancer
|
A |
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
rs4713607
|
HLA-DPB2
|
cervical cancer
|
A |
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
rs3117039
|
HLA-DPB2
|
Hepatitis B
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population.
|
21750111 |
2011 |
rs1883414
|
HLA-DPB2
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.
|
19503088 |
2009 |
rs3117027
|
HLA-DPB2
|
Malignant tumor of cervix
|
|
0.020 |
GeneticVariation |
BEFREE |
<i>Conclusion.</i> HLA-DP gene polymorphisms (HLA-DPB1⁎03:01, DPB1⁎04:02, DPB1⁎13:01, rs9277535, and rs3117027) were significantly associated with cervical cancer.
|
30009173 |
2018 |
rs3117027
|
HLA-DPB2
|
Malignant tumor of cervix
|
|
0.020 |
GeneticVariation |
BEFREE |
No association was observed between rs3117027 and risk of cervical cancer.
|
24403192 |
2014 |
rs6457715
|
HLA-DPB2
|
Adult Classical Hodgkin Lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
rs6457715, located near the HLA-DPB1 gene, is associated with EBV-positive cHL and suggests this region as a novel susceptibility locus for cHL.
|
26404960 |
2015 |
rs6457715
|
HLA-DPB2
|
Classical Hodgkin's Lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
rs6457715, located near the HLA-DPB1 gene, is associated with EBV-positive cHL and suggests this region as a novel susceptibility locus for cHL.
|
26404960 |
2015 |